Glyree-M 2 Tablet PR is a combination oral antidiabetic medication containing Glimepiride 2 mg and Metformin 500 mg, primarily indicated for the management of type 2 diabetes mellitus. Glimepiride, a sulfonylurea class agent, functions by stimulating pancreatic beta cells to increase insulin secretion, thereby improving glycemic control. Metformin, a biguanide, enhances insulin sensitivity by decreasing hepatic glucose production and increasing peripheral glucose uptake and utilization. The combination of these two agents provides complementary mechanisms of action, resulting in improved blood glucose regulation in patients inadequately controlled by diet, exercise, and monotherapy. Glyree-M 2 Tablet PR is typically prescribed as part of a comprehensive diabetes management plan, including lifestyle modifications such as diet and physical activity. It is important to monitor blood glucose levels regularly to adjust dosing and minimize the risk of hypoglycemia, a potential adverse effect primarily associated with Glimepiride. Metformin’s common side effects include gastrointestinal disturbances, which are generally transient. Caution is advised in patients with renal impairment, hepatic dysfunction, or conditions predisposing to lactic acidosis. Glyree-M 2 Tablet PR should be used under medical supervision, with periodic assessment of renal function and glycemic parameters to ensure optimal therapeutic outcomes.

Dosage & How to Use